In Situ Schiff Reagent Synthesis for Stable Staining

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The instability of commercial Schiff's reagents used in the Periodic-Acid Schiff's assay (PAS) leads to inconsistent staining quality over time, and the presence of crystalline precipitates can result in false positives during fungal detection.

Innovation Solution

The development of compositions and methods for synthesizing a Schiff's reagent in situ directly on a biological specimen, using a dye composition with a 4-Benzhydrylidene-2,5-cyclohexadien-1-imine core and a sulfite or SO2 source, which prevents precipitate formation and maintains stability for at least 1 year.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If commercial Schiff's reagent is stored and used over time, then staining capability is maintained, but reagent stability deteriorates and crystalline precipitates form

Engineering Contradiction:
Improvestaining quality consistencyVSAvoidreagent stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The Schiff's reagent is divided into two separate stable components: a dye composition (containing para-rosaniline or other viable dyes) and a sulfite composition (containing sodium metabisulfite or other sulfite sources). These segmented components are stored separately and only combined in situ during the staining procedure, preventing premature degradation and precipitate formation while maintaining staining capability throughout storage.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an intermediary mechanism by requiring the combination of dye and sulfite components only at the moment of application to the biological sample. This intermediary step (in situ synthesis) ensures that the unstable Schiff's reagent is generated fresh rather than stored, eliminating the stability issues associated with long-term storage of the complete reagent.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If crystalline precipitates are present in Schiff's reagent, then reagent is formed, but false positives occur during fungal detection

Engineering Contradiction:
Improvereagent formationVSAvoidfalse positive rate
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

By segmenting the reagent into separate dye and sulfite compositions that are combined only in situ during staining, the patent eliminates the formation of crystalline precipitates that cause false positives. The segmented components remain stable during storage and only form the complete reagent when applied to the sample, preventing precipitate-related interference.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent converts the potential harm of precipitate formation into a benefit by using the in situ synthesis approach. Instead of storing the complete reagent that forms precipitates, the system stores stable separate components that only combine to form the active reagent at the moment of application, thereby eliminating the harmful precipitates while maintaining reagent functionality.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Duration of action of stationary object

If Schiff's reagent is stored for extended periods, then availability is maintained, but staining quality deteriorates

Engineering Contradiction:
Improvestorage durationVSAvoidstaining quality
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent segments the Schiff's reagent into stable dye and sulfite components that can be stored separately for extended periods without degradation. The staining quality is maintained because the complete reagent is synthesized in situ at the time of use, ensuring optimal performance regardless of how long the individual components have been stored.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent prepares the dye and sulfite components in advance as stable, storeable forms, but the actual reagent formation is delayed until the moment of application. This preliminary preparation of stable components allows for extended storage availability while preserving staining quality through timely in situ synthesis.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach ensures consistent staining quality equivalent to commercial Schiff's reagents while preventing precipitate formation, thereby avoiding false positives and maintaining reagent stability for extended periods.

Implementation Method 1

synthesizing a Schiff's reagent in situ directly on a biological specimen, using a dye composition with a 4-Benzhydrylidene-2,5-cyclohexadien-1-imine core and a sulfite or SO2 source

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

A solution including a Schiff's reagent will combine chemically with aldehydes in a sample to form a bright red, purple, or magenta product

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 3

the chromophore reforms, and color is produced

Methodology Applied
Scientific EffectColor formation:

Data Source

PatentUS20250164360A1On-slide synthesis of a schiff reagent
Publication Date: 2025.05.22 VENTANA MEDICAL SYSTEMS INC
  • US20250164360A1 patent drawing
  • US20250164360A1 patent drawing
  • US20250164360A1 patent drawing

AI summary

The present disclosure is directed to compositions, kits, and methods for synthesizing a Schiff's reagent in situ, i.e., directly on a substrate, such as within a puddle disposed on the surface of a substrate. In some embodiments, the kits comprise at least a dye composition and a sulfite composition. In some embodiments, the dye composition comprises a compound having a 4-Benzhydrylidene-2,5-cyclohexadien-1-imine core functionalized to include at least two substituted or unsubstituted amine groups, wherein the compound has a molecular weight ranging from between about 300 g/mol to about 600 g/mol. In some embodiments, the dye composition optionally includes an acid. In some embodiments, the sulfite composition comprises a sulfite or SO2 source.